Frank J. Jeurissen

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer, Esmée A. Dijkstra, Boudewijn van Etten et al. · The Lancet Oncology · 2020 · 1.6K citations · Full text

Medicine, Oncology, Surgery +17

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man et al. · The Lancet Oncology · 2018 · 419 citations · Full text

Medicine, Oncology, Pharmacology +16

A cost analysis of upfront DPYD genotype–guided dose individualisation in fluoropyrimidine-based anticancer therapy

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man et al. · European Journal of Cancer · 2018 · 90 citations · Full text

Medicine, Oncology, Pharmacoeconomics +17

Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phospholipase D, MAP kinase, and IL-6 production.

Annemieke Kavelaars, D Broeke, Frank J. Jeurissen et al. · The Journal of Immunology · 1994 · 73 citations · Full text

Life Sciences, Immunology, Pharmacology +13

Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase.

Frank J. Jeurissen, Annemieke Kavelaars, D Broeke et al. · The Journal of Immunology · 1994 · 44 citations

Life Sciences, Biochemistry, Pharmacology +13